Table 2 Demographics of recipients included in this study
Clinical Values | DBCD (n = 383) | DBD (n = 140) | P |
|---|---|---|---|
Age(years) | 42.5 ± 11.1 | 43.1 + 11.6 | 0.85 |
Gender (%Female) | 37.6 | 32.1 | 0.26 |
Preoperative Cr(μmol/L) | 931.2 ± 287.4 | 1033.6 ± 324 | 0.06 |
Previous transplants, n (%) | |||
 First transplant | 374(97.7) | 135(96.4) | 0.54 |
 Second transplant | 9(2.3) | 5(3.6) | |
PRA, n (%) | |||
  < 10% | 371(96.9) | 135(96.4) | 0.78 |
 10–50% | 12(3.1) | 5(3.6) | |
Induction therapy, n (%) | |||
 antithymocyte globulin | 291(76) | 39(27.9) | 0 |
 basiliximab | 92(24) | 101(72.1) | |
HLA mismatches, n (%) | |||
 0–1 | 274(71.5) | 106(75.7) | 0.22 |
 2–4 | 79(20.6) | 29(20.7) | |
 5–6 | 30 (7.9) | 5(3.6) | |